Evidence map›Paper›PMID 35405782›Full record

ArticleZhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi2022

[Prognostic significance of IKZF1 gene deletions in patients with B-cell acute lymphoblastic leukemia].

B Q Tang, Z H Cai, D N Lin, Z X Wang, X J Liang, Z P Fan, F Huang, Q F Liu, H S Zhou

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

B Q TangDepartment of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Z H CaiDepartment of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
D N LinDepartment of Hematology, Guangzhou Twelfth People's Hospital, Guangzhou 510515, China.
Z X WangDepartment of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
X J LiangDepartment of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Z P FanDepartment of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
F HuangDepartment of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Q F LiuDepartment of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
H S ZhouDepartment of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Southern Medical University · CNNanfang Hospital · CN

Funding

National Natural Science Foundation of China 82170163, 81970147, 81770170The Chinical Trial Funding of Nanfang Hospital LC2016ZD009/2019CR012The Clinical Trial Funding of SMU 2016A020215112The Science and Technology Planning Project of Guangdong Province 2017A030313601
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Burkitt LymphomaIkaros Transcription FactorPrecursor B-Cell Lymphoblastic Leukemia-LymphomaAcute DiseaseChildGene DeletionHumansPrognosisIkaros Transcription FactorIKZF1 protein, humanAllogeneic hematopoietic stem cell transplantationGene, IKZF1Leukemia, B-cell, acute

Identifiers

PMID35405782
PMCPMC9072070
OpenAlexW4223443985

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.